LEVULAN

Serial Number 75110411
Registration 2124359
800

Registration Progress

Application Filed
May 28, 1996
Under Examination
Jul 15, 1997
Approved for Publication
Mar 21, 1997
Published for Opposition
Apr 22, 1997
Registered
Dec 23, 1997

Trademark Image

LEVULAN

Basic Information

Serial Number
75110411
Registration Number
2124359
Filing Date
May 28, 1996
Registration Date
December 23, 1997
Published for Opposition
April 22, 1997
Renewal Date
December 23, 2017
Drawing Code
1

Status Summary

Current Status
Active
Status Code
800
Status Date
Jan 1, 2018
Registration
Registered
Classes
005

Rights Holder

SUN PHARMACEUTICAL INDUSTRIES, INC.

03
Address
2 INDEPENDENCE WAY
PRINCETON, NJ 08540

Ownership History

DUSA Pharmaceuticals, Inc.

Original Applicant
03
Mississauga, ON L4V 1P1 CA

DUSA Pharmaceuticals, Inc.

Owner at Publication
03
Mississauga, ON L4V 1P1 CA

DUSA Pharmaceuticals, Inc.

Original Registrant
03
Billerica, MA

SUN PHARMACEUTICAL INDUSTRIES, INC.

New Owner After Registration #1
03
PRINCETON, NJ

Legal Representation

Attorney
Craig Kuchii

USPTO Deadlines

Next Deadline
874 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 1997-12-23)
Due Date
December 23, 2027
Grace Period Ends
June 23, 2028

Application History

39 events
Date Code Type Description Documents
Jun 20, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 20, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
May 1, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 22, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 22, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 22, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 22, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 22, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Sep 22, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 1, 2018 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) Loading...
Jan 1, 2018 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Jan 1, 2018 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 1, 2018 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Dec 4, 2017 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Dec 4, 2017 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 23, 2016 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Apr 11, 2016 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 11, 2016 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 4, 2008 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Jan 4, 2008 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Dec 13, 2007 PLGL A ASSIGNED TO PARALEGAL Loading...
Dec 7, 2007 89AF I REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED Loading...
Dec 7, 2007 MAIL I PAPER RECEIVED Loading...
Apr 24, 2007 CFIT O CASE FILE IN TICRS Loading...
Feb 21, 2004 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Dec 22, 2003 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Loading...
Dec 23, 1997 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 5, 1997 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Nov 4, 1997 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 29, 1997 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 30, 1997 IUAF S USE AMENDMENT FILED Loading...
Jul 15, 1997 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 22, 1997 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 21, 1997 NPUB O NOTICE OF PUBLICATION Loading...
Feb 20, 1997 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 30, 1997 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 6, 1996 CNRT F NON-FINAL ACTION MAILED Loading...
Oct 28, 1996 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 24, 1996 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
pharmaceutical preparations employing 5-aminolevulinic acid for use in therapy or diagnoses of malignant and non-malignant dermatologic, urologic and gynecologic tissues, lesions of the skin; conjunctiva; respiratory mucosa; digestive tract, including esophageal, gastric, duodenal, jejunal, ileal, colonic, and rectal mucosa; vaginal and cervical mucosa; endometrium; and other rapidly growing cells
First Use Anywhere: Mar 27, 1997
First Use in Commerce: Mar 27, 1997

Classification

International Classes
005